# SARS-CoV2 Antibodies in Pediatric Patients (COVID-19)

> **NCT04581148** · — · UNKNOWN · sponsor: **University of Erlangen-Nürnberg Medical School** · enrollment: 7000 (estimated)

## Conditions studied

- SARS-Cov2

## Interventions

- **DIAGNOSTIC_TEST:** Blood test antibodies against SARS-CoV-2

## Key facts

- **NCT ID:** NCT04581148
- **Lead sponsor:** University of Erlangen-Nürnberg Medical School
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-01
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-06-30
- **Target enrollment:** 7000 (ESTIMATED)
- **Last updated:** 2022-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04581148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04581148, "SARS-CoV2 Antibodies in Pediatric Patients (COVID-19)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04581148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*